- Home
- ADAP vs EFSI Comparison
ADAP vs EFSI Comparison
Compare ADAP & EFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- EFSI
- Stock Information
- Founded
- ADAP 2008
- EFSI 1881
- Country
- ADAP United Kingdom
- EFSI United States
- Employees
- ADAP N/A
- EFSI N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- EFSI Major Banks
- Sector
- ADAP Health Care
- EFSI Finance
- Exchange
- ADAP Nasdaq
- EFSI Nasdaq
- Market Cap
- ADAP 158.6M
- EFSI 167.5M
- IPO Year
- ADAP 2015
- EFSI N/A
- Fundamental
- Price
- ADAP $0.56
- EFSI $32.75
- Analyst Decision
- ADAP Strong Buy
- EFSI
- Analyst Count
- ADAP 4
- EFSI 0
- Target Price
- ADAP $2.79
- EFSI N/A
- AVG Volume (30 Days)
- ADAP 623.5K
- EFSI 10.3K
- Earning Date
- ADAP 03-05-2025
- EFSI 01-01-0001
- Dividend Yield
- ADAP N/A
- EFSI 3.79%
- EPS Growth
- ADAP N/A
- EFSI 62.68
- EPS
- ADAP N/A
- EFSI 4.32
- Revenue
- ADAP $175,041,000.00
- EFSI $70,233,000.00
- Revenue This Year
- ADAP $204.91
- EFSI N/A
- Revenue Next Year
- ADAP N/A
- EFSI N/A
- P/E Ratio
- ADAP N/A
- EFSI $7.58
- Revenue Growth
- ADAP 146.27
- EFSI 11.27
- 52 Week Low
- ADAP $0.53
- EFSI $27.02
- 52 Week High
- ADAP $2.05
- EFSI $36.93
- Technical
- Relative Strength Index (RSI)
- ADAP 40.12
- EFSI N/A
- Support Level
- ADAP $0.55
- EFSI N/A
- Resistance Level
- ADAP $0.61
- EFSI N/A
- Average True Range (ATR)
- ADAP 0.03
- EFSI 0.00
- MACD
- ADAP -0.00
- EFSI 0.00
- Stochastic Oscillator
- ADAP 12.14
- EFSI 0.00
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.
About EFSI Eagle Financial Services Inc Common Stock
Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending, and Wealth Management. It generates a majority of its revenue from the Community Banking segment.